Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › South Bend › NPI 1518516533
Lab

Labcorp Indiana INC

Labcorp Indiana INC was paid $4.00M by Medicaid between Sep 2019 and Oct 2021, across 172 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 40% of everything it billed.

33Billing provider infoLABCORP INDIANA INC
SOUTH BEND, IN 46601
33aNPI1518516533assigned 09/11/2019
33bProvider typeClinical Medical Laboratory
28Total paid$4.00M
24GClaims259,176
24DCodes billed172
24AFirst – last monthSep 2019 – Oct 2021
Compared with peers

Next to other Clinical Medical Laboratory providers in Indiana

Rank by total paid#8 of 66
Median peer was paid$53K
This provider vs. median76×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201946,427$439K
2020138,167$2.12M
202174,582$1.45M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 40% 29,238 22,428 $1.58M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 6.1% 9,214 7,459 $242K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 6.0% 9,182 7,436 $242K
80050 General health panel 3.4% 3,420 2,697 $134K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.9% 2,767 2,132 $118K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 2.7% 6,040 4,976 $109K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2.0% 3,567 2,946 $82K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 2.0% 3,481 2,470 $81K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2.0% 5,464 4,093 $80K
80061 Lipid panel 1.8% 8,529 6,968 $70K
87653 1.7% 2,827 2,220 $67K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.6% 2,388 2,051 $64K
160 more codes
84443 Thyroid stimulating hormone (TSH) 1.6% 6,715 $62K
80053 Comprehensive metabolic panel 1.6% 11,799 $62K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.5% 3,455 $62K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.3% 3,383 $52K
87086 Culture, bacterial; quantitative colony count, urine 1.1% 8,376 $43K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 10,887 $42K
86481 1.0% 738 $42K
80074 <1% 899 $32K
83036 Hemoglobin; glycosylated (A1C) <1% 5,066 $29K
80081 <1% 662 $29K
36415 Collection of venous blood by venipuncture <1% 20,404 $28K
83655 <1% 3,688 $26K
86003 <1% 1,032 $22K
85027 <1% 5,511 $21K
84439 <1% 3,097 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 773 $19K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 673 $19K
87186 <1% 3,294 $18K
82728 <1% 2,011 $17K
83516 <1% 1,031 $17K
87081 <1% 3,587 $16K
86762 <1% 1,467 $16K
87340 <1% 2,429 $15K
83970 <1% 831 $15K
84481 <1% 1,257 $14K
86803 <1% 1,233 $14K
80048 Basic metabolic panel (calcium, ionized) <1% 3,695 $13K
87077 <1% 2,289 $13K
82607 <1% 1,394 $13K
86235 <1% 184 $12K
86850 <1% 2,174 $11K
86038 <1% 1,228 $11K
84702 <1% 1,292 $10K
87536 <1% 228 $10K
88141 <1% 718 $10K
80055 <1% 310 $10K
82570 <1% 3,328 $9K
84403 <1% 510 $9K
84153 <1% 740 $9K
87088 <1% 1,632 $9K
83550 <1% 1,631 $8K
86787 <1% 868 $8K
82950 <1% 2,125 $7K
87522 Neg quan hep c or qual rna <1% 283 $7K
83540 <1% 1,798 $7K
86376 <1% 630 $7K
81001 <1% 3,803 $6K
83735 <1% 1,898 $6K
82105 <1% 512 $6K
83001 <1% 469 $6K
82784 <1% 879 $6K
86140 <1% 1,575 $5K
82043 <1% 1,489 $5K
86901 <1% 2,004 $5K
87070 <1% 804 $5K
84146 <1% 321 $5K
86900 <1% 1,916 $5K
86255 <1% 501 $5K
82746 <1% 467 $4K
83525 <1% 487 $4K
84156 <1% 2,012 $4K
85610 <1% 1,796 $4K
80177 <1% 524 $4K
86160 <1% 215 $3K
86800 <1% 331 $3K
86592 <1% 1,044 $3K
80069 <1% 771 $3K
86769 <1% 56 $3K
86780 <1% 348 $3K
85652 <1% 1,732 $3K
86696 <1% 227 $3K
87205 <1% 968 $3K
82951 <1% 331 $3K
82677 <1% 157 $3K
82670 <1% 135 $3K
80164 <1% 366 $3K
87493 <1% 128 $3K
85060 <1% 286 $3K
0065U <1% 2,486 $3K
83002 <1% 214 $2K
84144 <1% 189 $2K
80076 <1% 506 $2K
87046 <1% 182 $2K
86200 <1% 184 $2K
84550 <1% 705 $2K
82785 <1% 223 $2K
86695 <1% 227 $2K
86334 <1% 173 $2K
86336 <1% 152 $2K
84165 <1% 278 $2K
87449 <1% 194 $1K
87427 <1% 184 $1K
85660 <1% 339 $1K
86431 <1% 355 $1K
86225 <1% 121 $1K
80197 <1% 247 $1K
88142 <1% 108 $1K
83880 <1% 77 $1K
87045 <1% 182 $1K
87631 <1% 17 $1K
82533 <1% 89 $1K
80175 <1% 157 $1K
82248 <1% 336 $967.65
87147 <1% 141 $966.16
87328 <1% 117 $925.04
87329 <1% 118 $898.47
84100 <1% 515 $884.77
86360 <1% 30 $882.42
82140 <1% 137 $874.75
86706 <1% 112 $856.91
87808 <1% 72 $760.58
83690 <1% 249 $759.31
87799 <1% 50 $738.24
82550 <1% 352 $737.17
80178 <1% 182 $692.47
82652 <1% 42 $649.71
82565 <1% 251 $643.22
87660 <1% 41 $619.57
87529 <1% 19 $618.67
84460 <1% 192 $607.58
85730 <1% 172 $602.07
86359 <1% 32 $563.27
84703 <1% 105 $500.10
84155 <1% 228 $446.69
82747 <1% 41 $432.54
86147 <1% 23 $420.08
84450 <1% 135 $412.33
87510 <1% 41 $410.01
87480 <1% 41 $406.01
82952 <1% 156 $377.56
80183 <1% 58 $367.18
82977 <1% 108 $326.97
84402 <1% 21 $317.93
85045 <1% 146 $301.74
85018 <1% 222 $285.06
83520 <1% 42 $283.20
82627 <1% 14 $276.20
86256 <1% 18 $236.35
83883 <1% 35 $232.44
86304 <1% 26 $225.67
82947 <1% 85 $211.04
87075 <1% 62 $209.17
84305 <1% 14 $208.46
87210 <1% 72 $206.49
83615 <1% 112 $203.81
85014 <1% 167 $193.19
84630 <1% 42 $169.08
85379 <1% 27 $169.03
82310 <1% 62 $160.80
82150 <1% 59 $158.17
83630 <1% 18 $157.75
87206 <1% 32 $148.44
86618 <1% 18 $141.73
87338 <1% 18 $139.80
84134 <1% 27 $131.74
87102 <1% 15 $124.57
83721 <1% 35 $117.17
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 0% 52 $0.00
81229 0% 13 $0.00
81243 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.